Table 2 Univariate and multivariate logistic regression analysis

Gender

 Female

 Male

0.81

0.46–1.43

0.463

Age

  < 60

  ≥ 60

2.73

1.43–5.18

0.002

2.35

1.19–4.67

0.02

BMI(kg/m²)

  < 24

  ≥ 24

1.23

0.74–2.04

0.421

Tobacco use,

 No

 Yes

1.07

0.64–1.78

0.805

Alcohol use

 No

 Yes

0.94

0.48–1.84

0.864

RBC(10¹²/L)

0.8

0.5–1.27

0.347

HB(g/L)

0.99

0.97–1

0.069

WBC(10⁹ /L)

1.06

0.92–1.2

0.426

NEUT(10⁹ /L)

1.05

0.91–1.22

0.501

LYM(10⁹ /L)

0.98

0.8–1.18

0.804

MO(10⁹ /L)

3.34

0.62–17.87

0.159

Preoperative Chemotherapy

 No

 Yes

1.92

0.87–4.26

0.107

Preoperation Radiotherapy

 No

 Yes

4.22

1.32–13.48

0.015

4.57

1.29–16.21

0.019

ASA

  < 3

  ≥ 3

1.91

1.14–3.18

0.013

1.57

0.91–2.72

0.103

T stage

 T0 + T1 + T2

 T3 + T4

0.78

0.45–1.33

0.359

N stage

 N0 + N1

 N2 + N3

1.66

0.96–2.86

0.069

TNM stage

 0 + I + II

 III + IV

1.21

0.73–2.02

0.455

Location of cancer

 Upper

 Middle

0.86

0.37–1.96

0.714

 Lower

0.72

0.31–1.69

0.454

Histology of cancer

 Squamous cell carcinoma

 Adenocarcinoma

0.65

0.26–1.62

0.356

 Other

1.09

0.22–5.36

0.918

Surgical method

 Sweet

 Ivor-lewis

1.27

0.68–2.39

0.458

 McKeown

1.13

0.37–3.46

0.835

Lymph node dissection

 Two-field

 Three-field

1.11

0.67–1.84

0.693

Anastomotic methods

 Cervical anastomosis

 Thoracic anastomosis

1.43

0.84–2.42

0.185

Surgery time (hour)

1.2

1.02–1.4

0.025

1.25

1.06–1.48

0.007

NLR

  < 1.91

  ≥ 1.91

0.83

0.5–1.38

0.475

PLR

  < 121.01

  ≥ 121.01

0.62

0.37–1.03

0.066

MLR

  < 0.23

  ≥ 0.23

1.51

0.89–2.58

0.126

APR

  < 0.15

  ≥ 0.15

0.62

0.37–1.04

0.07

PNI

  < 48.6

  ≥ 48.6

0.5

0.3–0.85

0.01

0.52

0.3–0.9

0.02